The microscopic bacteria living in women’s bodies could be a powerful tool for personalised, non-invasive treatment and earlier diagnosis.
Similar Posts
MHRA crackdown on illegal ‘Botox’ after victims left seriously ill
More than 40 people hospitalised following suspected use of unlicensed botulinum toxin products.
MHRA Safety Roundup: September 2025
Summary of the latest safety advice for medicines and medical device users
Guidance: AI Airlock Phase 2 application
The call for application for phase 2 of the AI Airlock is now open. This page contains information on eligibility and how to apply
Field Safety Notices: 18 to 22 August 2025
List of Field Safety Notices from 18 to 22 August 2025.
BD BodyComm™ version 3.3 software used for BodyGuard infusion pumps, BodyGuard-T and T34 syringe drivers: Important steps to manage transition to Windows 11 (DSI/2025/006)
The BodyComm software currently uses Windows 10. Microsoft is transitioning to Windows 11 from 14 October 2025 which requires an updated cable to connect the pumps to the BodyComm software. These cables may not be available until after the Windows transition date.
Contact the MHRA
How to contact the MHRA for specific services or enquiries.